These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20131867)

  • 1. Mass spectrometry-based GPCR proteomics: comprehensive characterization of the human cannabinoid 1 receptor.
    Zvonok N; Xu W; Williams J; Janero DR; Krishnan SC; Makriyannis A
    J Proteome Res; 2010 Apr; 9(4):1746-53. PubMed ID: 20131867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized Proteomic Mass Spectrometry Characterization of Recombinant Human μ-Opioid Receptor Functionally Expressed in Pichia pastoris Cell Lines.
    Rosa M; Bech-Serra JJ; Canals F; Zajac JM; Talmont F; Arsequell G; Valencia G
    J Proteome Res; 2015 Aug; 14(8):3162-73. PubMed ID: 26090583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive proteomic mass spectrometric characterization of human cannabinoid CB2 receptor.
    Zvonok N; Yaddanapudi S; Williams J; Dai S; Dong K; Rejtar T; Karger BL; Makriyannis A
    J Proteome Res; 2007 Jun; 6(6):2068-79. PubMed ID: 17472360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cannabinoid 1 GPCR C-terminal domain interacts with bilayer phospholipids to modulate the structure of its membrane environment.
    Tiburu EK; Tyukhtenko S; Zhou H; Janero DR; Struppe J; Makriyannis A
    AAPS J; 2011 Mar; 13(1):92-8. PubMed ID: 21234731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based proteomics of human cannabinoid receptor 2: covalent cysteine 6.47(257)-ligand interaction affording megagonist receptor activation.
    Szymanski DW; Papanastasiou M; Melchior K; Zvonok N; Mercier RW; Janero DR; Thakur GA; Cha S; Wu B; Karger B; Makriyannis A
    J Proteome Res; 2011 Oct; 10(10):4789-98. PubMed ID: 21861534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-state NMR and molecular dynamics characterization of cannabinoid receptor-1 (CB1) helix 7 conformational plasticity in model membranes.
    Tiburu EK; Bowman AL; Struppe JO; Janero DR; Avraham HK; Makriyannis A
    Biochim Biophys Acta; 2009 May; 1788(5):1159-67. PubMed ID: 19366584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and mass spectroscopic analysis of human CB1 cannabinoid receptor functionally expressed using the baculovirus system.
    Xu W; Filppula SA; Mercier R; Yaddanapudi S; Pavlopoulos S; Cai J; Pierce WM; Makriyannis A
    J Pept Res; 2005 Sep; 66(3):138-50. PubMed ID: 16083441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, Purification and Characterization of the Human Cannabinoid 1 Receptor.
    Mallipeddi S; Zvonok N; Makriyannis A
    Sci Rep; 2018 Feb; 8(1):2935. PubMed ID: 29440756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-Assisted Protein Structure (LAPS): An Experimental Paradigm for Characterizing Cannabinoid-Receptor Ligand-Binding Domains.
    Janero DR; Korde A; Makriyannis A
    Methods Enzymol; 2017; 593():217-235. PubMed ID: 28750804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-expression of the human cannabinoid receptor coding region splice variants (hCB₁) affects the function of hCB₁ receptor complexes.
    Bagher AM; Laprairie RB; Kelly ME; Denovan-Wright EM
    Eur J Pharmacol; 2013 Dec; 721(1-3):341-54. PubMed ID: 24091169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding Site Characterization of AM1336, a Novel Covalent Inverse Agonist at Human Cannabinoid 2 Receptor, Using Mass Spectrometric Analysis.
    Mallipeddi S; Kreimer S; Zvonok N; Vemuri K; Karger BL; Ivanov AR; Makriyannis A
    J Proteome Res; 2017 Jul; 16(7):2419-2428. PubMed ID: 28374590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique agonist-bound cannabinoid CB1 receptor conformations indicate agonist specificity in signaling.
    Georgieva T; Devanathan S; Stropova D; Park CK; Salamon Z; Tollin G; Hruby VJ; Roeske WR; Yamamura HI; Varga E
    Eur J Pharmacol; 2008 Feb; 581(1-2):19-29. PubMed ID: 18162180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and characterization of human CB1 cannabinoid receptor in methylotrophic yeast Pichia pastoris.
    Kim TK; Zhang R; Feng W; Cai J; Pierce W; Song ZH
    Protein Expr Purif; 2005 Mar; 40(1):60-70. PubMed ID: 15721772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why less is more when generating tryptic peptides in bottom-up proteomics.
    Hildonen S; Halvorsen TG; Reubsaet L
    Proteomics; 2014 Sep; 14(17-18):2031-41. PubMed ID: 25044798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating Lys-N proteolysis and N-terminal guanidination for improved fragmentation and relative quantification of singly-charged ions.
    Carabetta VJ; Li T; Shakya A; Greco TM; Cristea IM
    J Am Soc Mass Spectrom; 2010 Jun; 21(6):1050-60. PubMed ID: 20207164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR solution structure of human cannabinoid receptor-1 helix 7/8 peptide: candidate electrostatic interactions and microdomain formation.
    Tyukhtenko S; Tiburu EK; Deshmukh L; Vinogradova O; Janero DR; Makriyannis A
    Biochem Biophys Res Commun; 2009 Dec; 390(3):441-6. PubMed ID: 19766594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 in a single ESI-MS spectrum.
    Espinosa LA; Ramos Y; Andújar I; Torres EO; Cabrera G; Martín A; Roche D; Chinea G; Becquet M; González I; Canaán-Haden C; Nelson E; Rojas G; Pérez-Massón B; Pérez-Martínez D; Boggiano T; Palacio J; Lozada Chang SL; Hernández L; de la Luz Hernández KR; Markku S; Vitikainen M; Valdés-Balbín Y; Santana-Medero D; Rivera DG; Vérez-Bencomo V; Emalfarb M; Tchelet R; Guillén G; Limonta M; Pimentel E; Ayala M; Besada V; González LJ
    Anal Bioanal Chem; 2021 Dec; 413(30):7559-7585. PubMed ID: 34739558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive de novo sequencing of new parvalbumin isoforms using a novel combination of bottom-up proteomics, accurate molecular mass measurement by FTICR-MS, and selected MS/MS ion monitoring.
    Carrera M; Cañas B; Vázquez J; Gallardo JM
    J Proteome Res; 2010 Sep; 9(9):4393-406. PubMed ID: 20586483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloud-point extraction and delipidation of porcine brain proteins in combination with bottom-up mass spectrometry approaches for proteome analysis.
    Shevchenko G; Sjödin MO; Malmström D; Wetterhall M; Bergquist J
    J Proteome Res; 2010 Aug; 9(8):3903-11. PubMed ID: 20586484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the role of proteolytic digestion on discovery and targeted proteomic measurements using liquid chromatography tandem mass spectrometry and design of experiments.
    Loziuk PL; Wang J; Li Q; Sederoff RR; Chiang VL; Muddiman DC
    J Proteome Res; 2013 Dec; 12(12):5820-9. PubMed ID: 24144163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.